These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 562517)

  • 1. Immunology of genitourinary malignancies.
    deKernion JB
    Proc Inst Med Chic; 1977; 31(5):151-2. PubMed ID: 562517
    [No Abstract]   [Full Text] [Related]  

  • 2. Genitourinary tumors and immunology.
    Lange PH
    Proc Inst Med Chic; 1978; 32(4):58-9. PubMed ID: 86188
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic testing of patients with genitourinary malignancies.
    Lange PH
    Urol Clin North Am; 1979 Oct; 6(3):587-97. PubMed ID: 388793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunology of malignant neoplasms of the urogenital system].
    Stratev S
    Khirurgiia (Sofiia); 1988; 41(1):46-52. PubMed ID: 3285081
    [No Abstract]   [Full Text] [Related]  

  • 5. A B O (H) blood group antigen determination in genitourinary neoplasms.
    Ghazizadeh M; Kagawa S
    Tokushima J Exp Med; 1983 Jun; 30(1-2):9-16. PubMed ID: 6685361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellular immunology of malignancies of urogenital tract (author's transl)].
    Ikegami K
    Nihon Hinyokika Gakkai Zasshi; 1977 Sep; 68(9):832-5. PubMed ID: 303720
    [No Abstract]   [Full Text] [Related]  

  • 7. Workshop on genitourinary cancer immunology.
    Natl Cancer Inst Monogr; 1978 Dec; (49):3-403. PubMed ID: 34798
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoembryonic antigen (CEA) in the plasma and urine of patients with urologic cancer.
    Thitipraserth A; Ablin R; Bush I; Guinan P
    Proc Inst Med Chic; 1973; 29(9):323. PubMed ID: 4737044
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy for genitourinary malignancies in the here and now!
    Slovin SF
    Urol Oncol; 2016 Apr; 34(4):169-70. PubMed ID: 26705103
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
    Zisman A; Pantuck AJ; Belldegrun A
    Isr Med Assoc J; 2000 Jan; 2(1):33-42. PubMed ID: 10892369
    [No Abstract]   [Full Text] [Related]  

  • 12. [PPD, PHA and Su-PS skin tests in genitourinary malignancies].
    Amano T; Koshida K; Nakajima K; Naito K; Hisazumi H
    Hinyokika Kiyo; 1985 Dec; 31(12):2107-11. PubMed ID: 3914213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
    Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy and gene therapy for genitourinary malignancies.
    Sokoloff MH; Belldegrun A
    Int J Urol; 1996 Jan; 3(1 Suppl):S4-18. PubMed ID: 24304019
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunotherapy and genitourinary neoplasia.
    Droller MJ
    Urol Clin North Am; 1980 Oct; 7(3):831-46. PubMed ID: 6161466
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modification of granulocyte phagocytosis by extracts from tumor antigens].
    Friedrich A; Schäning B; Walzel H; Glass W
    Allerg Immunol (Leipz); 1984; 30(1):34-42. PubMed ID: 6233861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genitourinary cancer].
    Akaza H
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):32. PubMed ID: 19195114
    [No Abstract]   [Full Text] [Related]  

  • 18. Genitourinary cancer.
    Hudes GR; Ozols RF; Schilder RJ
    Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
    [No Abstract]   [Full Text] [Related]  

  • 19. Segregation of the clinical course of transmissible venereal tumor with DL-A haplotypes in canine families.
    Taylor Bennett B; Taylor Y; Epstein R
    Transplant Proc; 1975 Dec; 7(4):503-5. PubMed ID: 1239106
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies.
    Delaney G; Jacob S; Barton M
    Cancer; 2005 Feb; 103(3):462-73. PubMed ID: 15612081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.